Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$20.8M |
| 2 |
Comcast
CMCSA
|
+$17.9M |
| 3 |
Mastercard
MA
|
+$17.9M |
| 4 |
McKesson
MCK
|
+$17.6M |
| 5 |
Reynolds Consumer Products
REYN
|
+$13.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$393M |
| 2 |
Entergy
ETR
|
+$96.9M |
| 3 |
CMS Energy
CMS
|
+$81.1M |
| 4 |
Consolidated Edison
ED
|
+$79.6M |
| 5 |
Ameren
AEE
|
+$72.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.65% |
| 2 | Financials | 7.8% |
| 3 | Healthcare | 7.73% |
| 4 | Consumer Discretionary | 6.21% |
| 5 | Consumer Staples | 6.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
White Mountains Insurance
WTM
$5.04B
| $234K | 0.01% |
+257
| New | +$266K |
|
|
COHR
727
DELISTED
Coherent Inc
COHR
| $234K | 0.01% |
2,195
-22,608
| -91% | -$3.16M |
|
|
CNST
728
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $234K | 0.01% |
+7,449
| New | +$259K |
|
|
DNKN
729
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $233K | 0.01% |
4,387
-2,503
| -36% | -$174K |
|
730
Ericsson
ERIC
$33.5B
| $232K | 0.01% |
28,681
-346,307
| -92% | -$2.83M |
|
731
Pembina Pipeline
PBA
$28.3B
| $232K | 0.01% |
+12,338
| New | +$405K |
|
732
Avnet
AVT
$7.27B
| $231K | 0.01% |
9,196
-8,123
| -47% | -$277K |
|
733
Northern Trust
NTRS
$33.6B
| $231K | 0.01% |
3,060
-35,851
| -92% | -$3.29M |
|
|
NVO
734
Novo Nordisk
NVO
$207B
| $231K | 0.01% |
+7,664
| New | +$228K |
|
735
Hawaiian Electric Industries
HE
$1.99B
| $228K | 0.01% |
+5,297
| New | +$245K |
|
736
Nu Skin
NUS
$231M
| $228K | 0.01% |
+10,434
| New | +$314K |
|
737
MSCI
MSCI
$41B
| $227K | 0.01% |
787
-3,422
| -81% | -$969K |
|
738
Cencora
COR
$60.7B
| $226K | 0.01% |
2,555
-42,135
| -94% | -$3.71M |
|
739
FMC
FMC
$1.38B
| $226K | 0.01% |
+2,763
| New | +$257K |
|
740
Invesco
IVZ
$14.1B
| $226K | 0.01% |
+24,906
| New | +$379K |
|
741
Annaly Capital Management
NLY
$17.5B
| $226K | 0.01% |
11,166
+7,596
| +213% | +$267K |
|
742
Zoom
ZM
$31.5B
| $225K | 0.01% |
+1,538
| New | +$152K |
|
|
FSCT
743
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $225K | 0.01% |
+7,108
| New | +$222K |
|
744
ATI
ATI
$28.2B
| $224K | 0.01% |
26,380
+8,496
| +48% | +$136K |
|
|
SI
745
DELISTED
Silvergate Capital Corporation
SI
| $224K | 0.01% |
+23,489
| New | +$332K |
|
746
Curtiss-Wright
CW
$23.5B
| $223K | 0.01% |
+2,410
| New | +$309K |
|
747
Photronics
PLAB
$1.8B
| $223K | 0.01% |
21,697
+1,365
| +7% | +$17.9K |
|
748
Workhorse Group
WKHS
$35.3M
| $223K | 0.01% |
41
+14
| +52% | +$120K |
|
|
PFPT
749
DELISTED
Proofpoint, Inc.
PFPT
| $223K | 0.01% |
2,175
-10,045
| -82% | -$1.17M |
|
750
Bruker
BRKR
$9.07B
| $222K | 0.01% |
6,178
-7,738
| -56% | -$359K |
|
Similar funds
Michael Gelband's Q1 2020 Portfolio in Review
As of Q1 2020, Michael Gelband held 1,928 positions worth $1.82B, down 66% from $5.33B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Michael Gelband withdrew a net $2.93B in Q1 2020, closing 898 positions and reducing 384 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $393M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Michael Gelband opened a new position in Mastercard worth $14.5M.
- Michael Gelband's largest Q1 2020 buy was Mastercard: 60,087 shares worth $14.5M.
- Michael Gelband added most to State Street Industrial Select Sector SPDR ETF in Q1 2020, an estimated $20.8M increase.
- Michael Gelband's biggest Q1 2020 reduction was Entergy, cutting an estimated $96.9M.
- Michael Gelband fully exited State Street SPDR S&P 500 ETF Trust in Q1 2020, selling an estimated $393M.
- Michael Gelband's ten largest holdings make up 32% of its $1.82B portfolio in Q1 2020.
- Michael Gelband opened 442 new positions and closed 898 in Q1 2020.
- Michael Gelband's portfolio value fell 66% quarter-over-quarter to $1.82B.
Based on ExodusPoint Capital Management's 13F filing for Q1 2020, filed 15 May 2020.